Treatment of levodopa induced dyskinesias with Levetiracetam

被引：0
|
作者：
Richardson, D.
Eisa, M.
Toenjes, A.
Bajwa, R.
Miller, D.
Jabbari, B.
机构：
来源：
MOVEMENT DISORDERS | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
800
引用
收藏
页码：S245 / S245
页数：1
相关论文
共 50 条
  • [1] BUSPIRONE IN THE TREATMENT OF LEVODOPA INDUCED DYSKINESIAS
    KLEEDORFER, B
    LEES, AJ
    STERN, GM
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (04): : 376 - 377
  • [2] Levetiracetam for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease
    Stathis, P.
    Konitsiotis, S.
    Tagaris, G.
    Peterson, D.
    MOVEMENT DISORDERS, 2011, 26 (02) : 264 - 270
  • [3] Treatment of levodopa-induced dyskinesias with donepezil
    Caroff, SN
    Martine, R
    Kleiner-Fisman, G
    Eisa, M
    Lorry, A
    Gallop, R
    Stern, MB
    Duda, JE
    PARKINSONISM & RELATED DISORDERS, 2006, 12 (04) : 261 - 263
  • [4] Treatment of levodopa-induced dyskinesias with donepezil
    Caroff, SN
    Martine, R
    Kleiner-Fisman, G
    Eisa, M
    Stern, MB
    Duda, JE
    MOVEMENT DISORDERS, 2006, 21 : S120 - S121
  • [5] Clozapine for the treatment of levodopa-induced dyskinesias
    Del Dotto, P
    Bonuccelli, U
    LANCET NEUROLOGY, 2004, 3 (05): : 268 - 268
  • [6] DEANOL IN TREATMENT OF LEVODOPA-INDUCED DYSKINESIAS
    KLAWANS, HL
    TOPEL, JL
    BERGEN, D
    NEUROLOGY, 1975, 25 (03) : 290 - 293
  • [7] DEANOL IN TREATMENT OF LEVODOPA-INDUCED DYSKINESIAS
    MILLER, E
    NEUROLOGY, 1974, 24 (02) : 116 - 119
  • [8] Medical treatment of levodopa-induced dyskinesias
    Rascol, O
    ANNALS OF NEUROLOGY, 2000, 47 (04) : S179 - S188
  • [9] NICOTINE AS ADJUVANT TREATMENT FOR LEVODOPA-INDUCED DYSKINESIAS
    Relja, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 205 - 205
  • [10] Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease
    Zesiewicz, TA
    Sullivan, KL
    Maldonado, JL
    Tatum, WO
    Hauser, RA
    MOVEMENT DISORDERS, 2005, 20 (09) : 1205 - 1209
12345